(Q40503568)

21 September 2017

title

An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application (English)

1 reference

21 September 2017

0 references

Itzchak Samina

1

1 reference

21 September 2017

Yevgeny Khinich

series ordinal

2

1 reference

21 September 2017

Michael Simanov

series ordinal

3

1 reference

21 September 2017

Mertyn Malkinson

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

21 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

41

1 reference

21 September 2017

page(s)

4955-4958

1 reference

West Nile virus: a growing concern?

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Recent advancement in flavivirus vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Vaccines and animal models for arboviral encephalitides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Traditional and novel approaches to flavivirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Direct (non-vector) transmission of West Nile virus in geese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Use of live and inactivated vaccines in the control of West Nile fever in domestic geese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Absence of humoral response in flamingos and red-tailed hawks to experimental vaccination with a killed West Nile virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.052

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.03.052

1 reference

21 September 2017

1 reference